Clinical Drug Experience Knowledgebase

Acute Disease (Phase 1)

Adenoviridae Infections (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Transitional Cell (Phase 2)

Communicable Diseases (Phase 2)

Cytomegalovirus Infections (Phase 2)

Disease (Phase 1)

Epstein-Barr Virus Infections (Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 1)

Hemophilia A (Phase 2)

Hemophilia B (Phase 1)

Infections (Phase 2)

Leukemia (Phase 2)

Leukemia, B-Cell (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Multiple Myeloma (Phase 2)

Mycoses (Phase 2)

Myelodysplastic Syndromes (Phase 1)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 2)

Neuroblastoma (Phase 2)

Opportunistic Infections (Phase 2)

Ovarian Neoplasms (Phase 2)

Papilloma (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Preleukemia (Phase 1)

Sarcoma (Phase 2)

Sarcoma, Ewing (Phase 2)

Tuberculosis (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

X-Linked Combined Immunodeficiency Diseases (Phase 2)